PE/VC Fundraising - Acquisitions & Exits - Funding Rounds - Tell us about your Deals - Sign up for Newsletter

Forbion Capital Partners

Prexton Therapeutics raises $31 million in Series B Funding

NeRRe Therapeutics Raises £23 million in an oversubscribed Series B financing round.

Allecra Therapeutics, Germany/France-based biopharma company raises €22M led by Delos Capital

Forbion closes third life sciences fund, FCF III, raising over $200m, to invest in pharmaceuticals and medical devices

Akarna Therapeutics Ltd., UK/California-based biopharmaceutical company, closes $15m Series B from Forbion, New Science Ventures etc.

UK-based Replimune, a trans-atlantic oncolytics startup, nets $30M in Series A funding round involving Atlas, Forbion and Omega

Amgen buys Dezima Pharma, a biotechnology drug manufacturer, in $1.55 billion deal

Forbion closes its co-investment fund at €75M

Sanifit, the Spain-based biopharmaceutical company, raises €36.6M in a Series C financing round

Forbion portfolio company Cellnovo Group, a medical technology company specialising in diabetes, raises €32.4M in its IPO